RT Book, Section
A1 Jobst, Erin E.
A1 Panus, Peter C.
A1 Kruidering-Hall, Marieke
SR Print(0)
ID 1192815893
T1 Pharmacologic Management of Parkinson’s Disease and Other Movement Disorders
T2 Pharmacology for the Physical Therapist, 2e
YR 2020
FD 2020
PB McGraw-Hill Education
PP New York, NY
SN 9781259862229
LK accessphysiotherapy.mhmedical.com/content.aspx?aid=1192815893
RD 2023/10/02
AB CASE  STUDYL.S.  is  a  78-year-old  man  who  was  referred  to  physical  therapy  after  a  progressive  reduction  in  his  physical  capabilities  secondary  to  Parkinson’s  disease  diagnosed  7  years  ago.  The  patient  stated  that  he  did  not  require  medication  initially,  but  6  months  ago  he  was  started  on  a  combination  of  levodopa  and  carbidopa  when  his  signs  and  symptoms  had  worsened  and  his  neurologist  felt  it  was  time  to  begin  medication.  The  patient’s  chief  complaints  are  generalized  stiffness,  slow  movement,  and  a  resting  tremor  in  his  hands  and  arms.  He  also  feels  that  he  has  gotten  very  weak  over  the  last  several  months.  During  the  initial  evaluation,  the  physical  therapist  observed  that  the  patient  had  a  minimal  stooped  posture.  L.S.  also  had  limited  passive  and  active  range  of  motion  in  bilateral  hips  and  upper  extremities  in  flexion,  abduction,  and  external  rotation.  His  overall  functional  strength  was  diminished  for  his  age  and  he  had  extremely  poor  endurance.  Upon  interview  by  the  therapist,  L.S.  revealed  that  he  had  lost  25  lb  over  the  last  6  months  and  that  his  appetite  had  diminished  drastically.